| 产品描述: | Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. |
| 靶点: |
EP2:0.19 nM (EC50) |
| 体内研究: |
Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.328 ml |
11.64 ml |
23.279 ml |
| 5 mM |
0.466 ml |
2.328 ml |
4.656 ml |
| 10 mM |
0.233 ml |
1.164 ml |
2.328 ml |
| 50 mM |
0.047 ml |
0.233 ml |
0.466 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |